Literature DB >> 22454226

[The methods within the evaluation of disease management programmes in control-group designs using the example of diabetes mellitus - a systematic literature review].

A Drabik1, P T Sawicki, D Müller, A Passon, S Stock.   

Abstract

BACKGROUND: Disease management programmes (DMPs) were implemented in Germany in 2002. Their evaluation is required by law. Beyond the mandatory evaluation, a growing number of published studies evaluate the DMP for diabetes mellitus type 2 in a control-group design. As patients opt into the programme on a voluntary basis it is necessary to adjust the inherent selection bias between groups. The aim of this study is to review published studies which evaluate the diabetes DMP using a control-group design with respect to the methods used.
METHODS: A systematic literature review of electronic databases (PUBMED, Cochrane Library, EMBASE, MEDPILOT) and a hand search of reference lists of the relevant publications was conducted to identify studies evaluating the DMP diabetes mellitus in a control-group design.
RESULTS: 8 studies were included in the systematic literature review. 4 studies gathered retrospective claims data from sickness funds, one from physician's records, one study used prospective data from ambulatory care, and 2 studies were based on one patient survey. Methods used for adjustment of selection bias included exact matching, matching using propensity score methods, age-adjusted and sex-separated analysis, and adjustment in a regression model/analysis of covariance. One study did not apply adjustment methods. The intervention period ranged from 1 day to 4 years. Considered outcomes of studies (surrogate parameter, diabetes complications, mortality, quality of life, and claim data) depended on the database.
CONCLUSION: In the evaluation of the DMP diabetes mellitus based on a control-group design neither the database nor the methods used for selection bias adjustment were consistent in the available studies. Effectiveness of DMPs cannot be judged based on this review due to heterogeneity of study designs. To allow for a comprehensive programme evaluation standardised minimum requirements for the evaluation of DMPs in the control group design are required. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22454226     DOI: 10.1055/s-0031-1301273

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  6 in total

Review 1.  Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness.

Authors:  Sabine Fuchs; Cornelia Henschke; Miriam Blümel; Reinhard Busse
Journal:  Dtsch Arztebl Int       Date:  2014-06-27       Impact factor: 5.594

2.  Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008-2010.

Authors:  Kayvan Bozorgmehr; Miguel San Sebastian; Hermann Brenner; Oliver Razum; Werner Maier; Kai-Uwe Saum; Bernd Holleczek; Antje Miksch; Joachim Szecsenyi
Journal:  Int J Equity Health       Date:  2015-03-10

3.  Social disparities in Disease Management Programmes for coronary heart disease in Germany: a cross-classified multilevel analysis.

Authors:  Kayvan Bozorgmehr; Werner Maier; Hermann Brenner; Kai-Uwe Saum; Christian Stock; Antje Miksch; Bernd Holleczek; Joachim Szecsenyi; Oliver Razum
Journal:  J Epidemiol Community Health       Date:  2015-06-16       Impact factor: 3.710

4.  Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study.

Authors:  Michael Mehring; Ewan Donnachie; Florian Cornelius Bonke; Christoph Werner; Antonius Schneider
Journal:  Diabetol Metab Syndr       Date:  2017-05-18       Impact factor: 3.320

5.  Selective enrollment in Disease Management Programs for coronary heart disease in Germany - An analysis based on cross-sectional survey and administrative claims data.

Authors:  Julia Röttger; Miriam Blümel; Reinhard Busse
Journal:  BMC Health Serv Res       Date:  2017-04-04       Impact factor: 2.655

6.  The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study.

Authors:  Michael Laxy; Renée Stark; Christa Meisinger; Inge Kirchberger; Margit Heier; Wolfgang von Scheidt; Rolf Holle
Journal:  Diabetol Metab Syndr       Date:  2015-09-17       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.